Treatment patterns and patient journey in progressive pulmonary fibrosis: a cross-sectional survey.

ABSTRACT:

Background

For patients with interstitial lung diseases (ILDs) presenting with a progressive pulmonary fibrosis (PPF) phenotype, current knowledge of disease characteristics at diagnosis, patient journey, and treatment is limited. This study aimed to describe demographics and clinical experiences of patients presenting with PPF in a European real-world setting.

Methods

Data were analysed from the Adelphi Real World PPF-ILD Disease Specific Programme™, a cross-sectional survey of pulmonologists and rheumatologists in five European countries (France, Germany, Italy, Spain, United Kingdom) and internal medicine specialists (France) from April to October 2022. Physicians provided data for up to 12 consecutive patients with physician-confirmed ILD with a progressive phenotype oth

SUBMITTER: Chaudhuri N 

PROVIDER: S-EPMC11465623 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature